Sirnaomics Bets On RNAi In China With First IND Approval

 
• By Brian Yang
  
Alan Lu
Alan Lu, EVP, Sirnaomics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip